← Home
Kyowa Kirin
-11.97%
Pharma / Pharma
🛍️ Products/Services
Kyowa Kirin is a global pharmaceutical and biotechnology company that specializes in the development and manufacture of medicines and therapies for serious and life-threatening medical conditions. The company's products and services include:
1. Pharmaceutical Products: Kyowa Kirin has a wide range of prescription drugs that are used to treat a variety of diseases and conditions, including cancer, kidney diseases, inflammatory disorders, and neurological disorders. Some of their notable products include:
- Poteligeo: A medication used for the treatment of certain types of cutaneous T-cell lymphoma.
- Nesp: A long-acting erythropoietin stimulating agent used to treat anemia associated with chronic kidney disease.
- Lumoxiti: An anti-cancer medication used for the treatment of hairy cell leukemia.
- Crysvita: A medication used for the treatment of X-linked hypophosphatemia, a rare inherited bone disorder.
2. Biosimilars: Kyowa Kirin also produces biosimilar drugs, which are highly similar to already approved biologic medicines. Bioimilars can provide more affordable treatment options for patients without compromising on quality. Some of Kyowa Kirin's biosimilars include:
- Hulio: A biosimilar of adalimumab, used for the treatment of various autoimmune diseases including rheumatoid arthritis and Crohn's disease.
- Movymia: A biosimilar of teriparatide, used for the treatment of osteoporosis.
3. Regenerative Medicine: Kyowa Kirin is also active in the field of regenerative medicine, developing therapies that use cells and tissues to restore or replace damaged tissues or organs. Some of their regenerative medicine products include:
- Heart Sheet: A regenerative therapy for patients with severe heart failure.
- Reprocell: A stem cell therapy for patients with neurological disorders.
4. Research and Development: Kyowa Kirin has a strong research and development program focused on discovering and developing new drugs and therapies for a range of diseases and conditions. The company collaborates with academic institutions and other companies to advance their pipeline of potential medicines.
5. Medical Devices: Kyowa Kirin also offers a range of medical devices, such as infusion pumps and injection pens, to help patients self-administer their medication at home.
6. Contract Manufacturing: Kyowa Kirin also provides contract manufacturing services for the production of pharmaceutical products, vaccines, medical devices, and other healthcare products. The company has manufacturing facilities in Japan, the UK, and the US.
See Company Q&A
1. Pharmaceutical Products: Kyowa Kirin has a wide range of prescription drugs that are used to treat a variety of diseases and conditions, including cancer, kidney diseases, inflammatory disorders, and neurological disorders. Some of their notable products include:
- Poteligeo: A medication used for the treatment of certain types of cutaneous T-cell lymphoma.
- Nesp: A long-acting erythropoietin stimulating agent used to treat anemia associated with chronic kidney disease.
- Lumoxiti: An anti-cancer medication used for the treatment of hairy cell leukemia.
- Crysvita: A medication used for the treatment of X-linked hypophosphatemia, a rare inherited bone disorder.
2. Biosimilars: Kyowa Kirin also produces biosimilar drugs, which are highly similar to already approved biologic medicines. Bioimilars can provide more affordable treatment options for patients without compromising on quality. Some of Kyowa Kirin's biosimilars include:
- Hulio: A biosimilar of adalimumab, used for the treatment of various autoimmune diseases including rheumatoid arthritis and Crohn's disease.
- Movymia: A biosimilar of teriparatide, used for the treatment of osteoporosis.
3. Regenerative Medicine: Kyowa Kirin is also active in the field of regenerative medicine, developing therapies that use cells and tissues to restore or replace damaged tissues or organs. Some of their regenerative medicine products include:
- Heart Sheet: A regenerative therapy for patients with severe heart failure.
- Reprocell: A stem cell therapy for patients with neurological disorders.
4. Research and Development: Kyowa Kirin has a strong research and development program focused on discovering and developing new drugs and therapies for a range of diseases and conditions. The company collaborates with academic institutions and other companies to advance their pipeline of potential medicines.
5. Medical Devices: Kyowa Kirin also offers a range of medical devices, such as infusion pumps and injection pens, to help patients self-administer their medication at home.
6. Contract Manufacturing: Kyowa Kirin also provides contract manufacturing services for the production of pharmaceutical products, vaccines, medical devices, and other healthcare products. The company has manufacturing facilities in Japan, the UK, and the US.
📊 Get full analytics about Kyowa Kirin
Sign up for free or log in👥 Free eBook for new users: "The Checklist Value Investor — A Smarter Way to Pick Stocks"